Back to today’s briefing

Story perspectives

New Discoveries in Cancer Genetics Propel Targeted Therapies

1/15/2025

27 2

Summary

Story summary

Genetic mutations and metabolic shifts are pivotal in cancer's relentless advance, underscoring the urgent call for targeted therapies. A groundbreaking study on CXCL1 sheds light on its crucial role in ovarian cancer, while Salk researchers unveil PIN1's impact on bladder cancer, suggesting a promising treatment that combines a PIN1 inhibitor with statins to combat tumor growth.

1 of 1

Story summary

Genetic mutations and metabolic shifts are pivotal in cancer's relentless advance, underscoring the urgent call for targeted therapies. A groundbreaking study on CXCL1 sheds light on its crucial role in ovarian cancer, while Salk researchers unveil PIN1's impact on bladder cancer, suggesting a promising treatment that combines a PIN1 inhibitor with statins to combat tumor growth.